Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
The cytoplasmic protein FROUNT can bind to chemokine receptors and enhance chemokine signalling. Here, the authors show that inhibiting FROUNT in macrophages either by knockdown of the gene or using the anti-alcoholism drug disulfiram, results in a reduction in tumour growth.
Guardado en:
Autores principales: | Yuya Terashima, Etsuko Toda, Meiji Itakura, Mikiya Otsuji, Sosuke Yoshinaga, Kazuhiro Okumura, Francis H. W. Shand, Yoshihiro Komohara, Mitsuhiro Takeda, Kana Kokubo, Ming-Chen Chen, Sana Yokoi, Hirofumi Rokutan, Yutaka Kofuku, Koji Ohnishi, Miki Ohira, Toshihiko Iizasa, Hirofumi Nakano, Takayoshi Okabe, Hirotatsu Kojima, Akira Shimizu, Shiro Kanegasaki, Ming-Rong Zhang, Ichio Shimada, Hiroki Nagase, Hiroaki Terasawa, Kouji Matsushima |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4d75cebbb8f47a985d666129063bb6d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study
por: Lisa Zirjacks, et al.
Publicado: (2021) -
Neuropatía por disulfiram: Comunicación de tres casos clínicos
por: Bevilacqua,Jorge A, et al.
Publicado: (2002) -
Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome
por: Michel Bernier, et al.
Publicado: (2020) -
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
por: Nathanael Fillmore, et al.
Publicado: (2021) -
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study
por: Nathanael Fillmore, et al.
Publicado: (2021)